- InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to be held on May 23th
- InVivo Therapeutics Reports First Quarter 2013 Financial Results, Provides Business Update
- InVivo Therapeutics Announces Call Notice for Exercise of Warrants and Partial Termination of Warrant Exchange Offer
- InVivo Therapeutics Announces Warrant Exchange Offer with Intent to Up-List to a National Securities Exchange
- InVivo TV Appearances
Developing Technology For
The Treatment of Spinal Cord Injuries
InVivo Therapeutics Corporation is developing and intends to commercialize groundbreaking technologies for the treatment of spinal cord injuries (SCI). InVivo intends to leverage it’s platform technology to deliver several products to the market.